Email Updates

You are here

Trial Summary Table

Trial Name Phase Start Date Sponsors Countries Population Candidate(s) Status Expected Completion Date
Benin Demonstration Project Demo Project Wednesday, October 1, 2014 CHU de Quebec Benin Women TDF/FTC (Truvada) Ongoing January 2017
Bridge to Scale Other Kenya Women, MSM Planned
Cabotegravir implant (Preclinical) Pre-clinical NIAID United States of America Men Cabotegravir (GSK 744) Completed
California Collaborative Treatment Group Consortium/ALERT (Active Linkage, Engagement and Retention to Reduce HIV) Demo Project Thursday, January 31, 2013 California Collaborative Treatment Group; University of California, San Diego; UCLA; University of Southern California; City of Long Beach Department of Health and Human Services; California HIV/AIDS Research Program; Gilead Sciences United States of America Men, MSM Ongoing July 2016
CAPRISA 018 I Sunday, January 1, 2017 Centre for the Aids Programme of Research in South Africa; Stichting Amsterdam Institute for Global Health and Development; Université Jean Monnet, Saint-Etienne Women tenofovir Ongoing December 2022
CDC 4323 II Monday, February 28, 2005 AIDS Research Consortium of Atlanta, Fenway Health, San Francisco Department of Public Health, US CDC United States of America MSM TDF Completed August 2009
CDC 4370/ Bangkok TFV Study III, II Thursday, June 30, 2005 Bangkok Metropolitan Administration Medical College and Vajira Hospital, Thailand Ministry of Health, US CDC Thailand Injecting drug users TDF Completed October 2014
CDC 494 Open Label Botswana Ministry of Health, CDC, Gilead Botswana Women, Men Completed
CDC Foundation Demonstration Project Demo Project Women, MSM Planned
CHAMPS Demo Project Sunday, July 31, 2011 NIAID South Africa Women, Men Ongoing October 2016

Pages